Page last updated: 2024-08-26

lopinavir and Allergy, Drug

lopinavir has been researched along with Allergy, Drug in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Abed, Y; Basile, MS; Cavalli, E; He, M; Maksimovic-Ivanic, D; Mazzon, E; Mijatovic, S; Nicoletti, F; Paskas, S; Rakocevic, S1
Bravo, I; Carosi, G; Clotet, B; del Arco, A; Echeverría, P; Gálvez, J; Gómez, JL; López, JC; López-Blazquez, R; Mariño, A; Moreno, A; Negredo, E; Ocampo, A; Pedrol, E; Pérez-Alvarez, N; Portilla, J; Prieto, A; Rubio, R; Viladés, C1
Manfredi, R; Sabbatani, S1
Bergonzi, S; Manfredi, R; Sabbatani, S1

Trials

1 trial(s) available for lopinavir and Allergy, Drug

ArticleYear
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
    Antiviral research, 2010, Volume: 85, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Withholding Treatment

2010

Other Studies

3 other study(ies) available for lopinavir and Allergy, Drug

ArticleYear
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.
    Investigational new drugs, 2019, Volume: 37, Issue:5

    Topics: Animals; Apoptosis; Autophagy; Cell Proliferation; Drug Hypersensitivity; Female; HIV Protease Inhibitors; Humans; In Vitro Techniques; Lopinavir; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Nitric Oxide; Reactive Oxygen Species; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
Serious, multi-organ hypersensitivity to lopinavir alone, involving cutaneous-mucous rash, and myeloid, liver, and kidney function.
    AIDS (London, England), 2006, Nov-28, Volume: 20, Issue:18

    Topics: Adult; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Exanthema; Female; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Lopinavir; Myelopoiesis; Pyrimidinones

2006
Clinical ritonavir and lopinavir hypersensitivity confirmed by a specific in vitro cellular allergen stimulation test.
    Current HIV research, 2007, Volume: 5, Issue:4

    Topics: Adult; Anti-HIV Agents; Drug Hypersensitivity; HIV Infections; Humans; Immunoassay; Lopinavir; Male; Protease Inhibitors; Pyrimidinones; Ritonavir

2007